High Dose Rate Brachytherapy as a Treatment Option in Endobronchial Tumors

Table 1

Patients’ and tumor characteristics.

Characteristic	Value
Median age (range), year	70 (37–92)
Median follow-up (range), months	17 (1.5–86)
Gender
Male	14 (61%)
Female	9 (39%)
Smoking history
Yes	13 (65%)
No	7 (35%)
Unknown	3
ECOG performance status
0	1 (4%)
1	17 (74%)
2	5 (22%)
Histology
Primary lung tumor	20 (87%)
SCC	9 (39%)
Adenocarcinoma	9 (39%)
Others	2 (9%)
Lung metastases	3 (13%)
Colon adenocarcinoma	2 (9%)
Thymoma	1 (4%)
Site
Central (trachea, main bronchi)	11 (48%)
Peripheral (lobar bronchi)	12 (52%)
Previous lung tumor
Yes	16 (70%)
No	7 (30%)
Treatment to previous lung tumor
Surgery	7 (30%)
Lobectomy	4 (17%)
Pneumonectomy	1 (4%)
Metastasectomy	2 (9%)
Radiotherapy	10 (43%)
Chemotherapy	9 (39%)
Photodynamic therapy	1 (4%)
Tumor visible on CT	18 (78%)

EBRT: external beam radiotherapy.